BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24879814)

  • 21. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
    Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
    J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.
    Müller AM; Florek M; Kohrt HE; Küpper NJ; Filatenkov A; Linderman JA; Hadeiba H; Negrin RS; Shizuru JA
    J Immunol; 2016 Nov; 197(10):4151-4162. PubMed ID: 27815446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
    Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.
    Chen BP; Galy A; Kyoizumi S; Namikawa R; Scarborough J; Webb S; Ford B; Cen DZ; Chen SC
    Blood; 1994 Oct; 84(8):2497-505. PubMed ID: 7522631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice.
    Mackenzie TC; Shaaban AF; Radu A; Flake AW
    J Pediatr Surg; 2002 Jul; 37(7):1058-64. PubMed ID: 12077771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioning.
    Ibrahim AA; Yahata T; Muguruma Y; Miyata T; Ando K
    Biochem Biophys Res Commun; 2019 Aug; 516(2):500-505. PubMed ID: 31230745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of marrow hematopoietic progenitor and stem cell content is not sufficient for enhanced syngeneic engraftment.
    Robinson S; van Os R; Sheridan T; Mauch P
    Stem Cells; 2000; 18(2):93-101. PubMed ID: 10742381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.
    Olson TS; Caselli A; Otsuru S; Hofmann TJ; Williams R; Paolucci P; Dominici M; Horwitz EM
    Blood; 2013 Jun; 121(26):5238-49. PubMed ID: 23667055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
    Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
    Front Immunol; 2020; 11():573406. PubMed ID: 33193358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of efficacies of allogeneic hematopoietic stem cell transplantations between different routes of administration in mice].
    Cai Y; Huang SL; Huang K; Chen HQ; Zhang XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):998-1004. PubMed ID: 17956678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
    Peranteau WH; Heaton TE; Gu YC; Volk SW; Bauer TR; Alcorn K; Tuschong LM; Johnson MP; Hickstein DD; Flake AW
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):293-305. PubMed ID: 19203720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.
    Alvarez M; Pierini A; Simonetta F; Baker J; Maas-Bauer K; Hirai T; Negrin RS
    Front Immunol; 2020; 11():614250. PubMed ID: 33488624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic stem cells from the marrow of mice treated with Flt3 ligand are significantly expanded but exhibit reduced engraftment potential.
    Mueller YM; Cramer DE; Huang Y; Exner BG; Ildstad ST
    Transplantation; 2002 Apr; 73(8):1177-85. PubMed ID: 11981407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation without irradiation.
    Waskow C; Madan V; Bartels S; Costa C; Blasig R; Rodewald HR
    Nat Methods; 2009 Apr; 6(4):267-9. PubMed ID: 19270698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
    Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
    Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal hematopoietic stem cell transplantation into beta-thalassemic mice.
    Bethel CA; Muragesh D; Harrison MR; Mohandas N; Rubin ER
    J Pediatr Surg; 1993 Oct; 28(10):1232-7; discussion 1237-8. PubMed ID: 7903357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal Hematopoietic Stem Cell Transplantation Fails to Fully Regenerate the B-Lymphocyte Compartment.
    Ghosn EE; Waters J; Phillips M; Yamamoto R; Long BR; Yang Y; Gerstein R; Stoddart CA; Nakauchi H; Herzenberg LA
    Stem Cell Reports; 2016 Jan; 6(1):137-49. PubMed ID: 26724903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts.
    Uchida N; Tsukamoto A; He D; Friera AM; Scollay R; Weissman IL
    J Clin Invest; 1998 Mar; 101(5):961-6. PubMed ID: 9486965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.